Literature DB >> 18423867

Spinal injection of IL-2 or IL-15 alters mechanical and thermal withdrawal thresholds in rats.

Juan P Cata1, Han-Rong Weng, Patrick M Dougherty.   

Abstract

IL-2 and IL-15 were tested for effects on responses to mechanical or thermal stimuli when spinally administered to male Sprague-Dawley rats with surgically implanted intrathecal catheters. Restricted doses of both IL-2 and IL-15 produced increased responsiveness to mechanical stimulation of the hindpaws. This effect lasted up to 48 h. IL-2 had biphasic effects on thermal responses whereas IL-15 produced thermal hypalgesia alone. These effects dissipated within 24h. These results suggest that IL-2 and IL-15 may participate in the generation of hyperalgesia in some pain conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423867      PMCID: PMC2702848          DOI: 10.1016/j.neulet.2008.03.074

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  43 in total

Review 1.  The role of neuroinflammation and neuroimmune activation in persistent pain.

Authors:  J A DeLeo; R P Yezierski
Journal:  Pain       Date:  2001-02-01       Impact factor: 6.961

Review 2.  Interleukin-2: from T cell growth and homeostasis to immune reconstitution of HIV patients.

Authors:  Marko Kryworuchko; Jacques Thèze
Journal:  Vitam Horm       Date:  2006       Impact factor: 3.421

3.  Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.

Authors:  N Azimi; S Jacobson; T Leist; T A Waldmann
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

4.  Treatment with interleukin-2 (IL-2) and interferon (IFN(alpha 2b)) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse.

Authors:  P Vivancos; A Grañena; J Sarrá; A Grañena
Journal:  Bone Marrow Transplant       Date:  1999-01       Impact factor: 5.483

5.  Kainate-activated currents in the ventral tegmental area of neonatal rats are modulated by interleukin-2.

Authors:  Jiang-Hong Ye; Steven S Zalcman; Liang Tao
Journal:  Brain Res       Date:  2005-07-12       Impact factor: 3.252

6.  Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice.

Authors:  Ray D Beck; Clive Wasserfall; Grace K Ha; Jesse D Cushman; Zhi Huang; Mark A Atkinson; John M Petitto
Journal:  Brain Res       Date:  2005-04-18       Impact factor: 3.252

Review 7.  The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.

Authors:  Thomas A Waldmann
Journal:  Nat Rev Immunol       Date:  2006-08       Impact factor: 53.106

Review 8.  Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy.

Authors:  J P Cata; H R Weng; B N Lee; J M Reuben; P M Dougherty
Journal:  Minerva Anestesiol       Date:  2006-03       Impact factor: 3.051

9.  Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients.

Authors:  M R Albertini; J A Hank; J H Schiller; M Khorsand; A A Borchert; J Gan; R Bechhofer; B Storer; R A Reisfeld; P M Sondel
Journal:  Clin Cancer Res       Date:  1997-08       Impact factor: 12.531

10.  IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.

Authors:  Waldiceu A Verri; Thiago M Cunha; Carlos A Parada; Xiao-qing Wei; Sérgio Henrique Ferreira; Foo Y Liew; Fernando Q Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

View more
  6 in total

Review 1.  Osteoarthritis joint pain: the cytokine connection.

Authors:  Rachel E Miller; Richard J Miller; Anne-Marie Malfait
Journal:  Cytokine       Date:  2014-07-24       Impact factor: 3.861

2.  Evaluation of serum cytokines in cats with and without degenerative joint disease and associated pain.

Authors:  Margaret E Gruen; Kristen M Messenger; Andrea E Thomson; Emily H Griffith; Lauren A Aldrich; Shelly Vaden; B Duncan X Lascelles
Journal:  Vet Immunol Immunopathol       Date:  2016-12-16       Impact factor: 2.046

3.  Painful, degenerating intervertebral discs up-regulate neurite sprouting and CGRP through nociceptive factors.

Authors:  Emerson Krock; Derek H Rosenzweig; Anne-Julie Chabot-Doré; Peter Jarzem; Michael H Weber; Jean A Ouellet; Laura S Stone; Lisbet Haglund
Journal:  J Cell Mol Med       Date:  2014-03-20       Impact factor: 5.310

4.  Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia.

Authors:  Luke Parkitny; Jarred Younger
Journal:  Biomedicines       Date:  2017-04-18

5.  Effects of vaccination with altered Peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.

Authors:  David H Tian; Chamini J Perera; Vasso Apostolopoulos; Gila Moalem-Taylor
Journal:  Front Neurol       Date:  2013-10-29       Impact factor: 4.003

6.  IL-15 and IL15RA in Osteoarthritis: Association With Symptoms and Protease Production, but Not Structural Severity.

Authors:  Sophie C Warner; Anjali Nair; Rahul Marpadga; Susan Chubinskaya; Michael Doherty; Ana M Valdes; Carla R Scanzello
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.